← Back to headlines
Citizens Maintains Positive Outlook on Opus Genetics Based on Viatris Partnership
Analysts reiterated their favorable stock rating for Opus Genetics, citing strong potential value creation from its ongoing commercial partnership with pharmaceutical giant Viatris.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Nigeria Reports 4.43 Percent Economic Growth in Second Quarter
30m ago
Prediction Platform Kalshi Permanently Bans George Santos Over Insider Trading
33m ago
Trump Administration Announces Major Oil Deal with Venezuela and Drug Pricing Pacts
1h ago
Aon Agrees to Acquire USI Insurance Services in $17 Billion Deal
1h ago